children+

asthma

Childhood asthma: the most common chronic disease globally

children+

asthma+

USA

715K new cases of childhood asthma every year

9.6M children having asthma in total

14M missed school days

$12 B annually

The prototype: Chameleon

a breathing toy + iPAD app => a

child that beats asthma attacks

The Breathe

Easy solution

The Team

P. Angelidis, Ph.D. is a telecom engineer, a prof. of mHealth and an entrepreneur. One of his startups, www.vidavo.eu is listed in the Athens SE

S. Hamilton, M.D. is a children asthma expert, working at Imperial College ST. Mary’s Hospital. She’s devoted in changing the way asthma care is delivered

J. Oliver Moore is a PhD student of the New Media Medicine research group in the Media Lab. John is a physician and technologist working to fundamentally change the role that patients can play in their

N. Papachristou, M. Sc. is a medical device expert with 5 years of experience. . He is also a well known medical blogger and a narrator at TEDxAthens 2010

M. Psymarnou holds an MBA and has a 10 years experience on ehealth business models and marketing

Competences

Proven record on successfully running

the research to market route

Research results on social media

incentive schemes for children

European Patent on a Mobile Asthma

Management Device

What more do we offer?competition

Breathe Easy Asthmapolis Smartinhaler

Tracking Time √ √ √Tracking Place √ √

Medication Volume √

Medication Reminder √ √ √Incentives Platform √

Collaborative Space √ ? ?

Fun to use √

$12.4 B: Global Asthma Market

1.5%: Global asthma market Compound Annual Growth Rate

$12.4 B (2009) -> $14 B (2017)

$5.3 B: Sales for patient monitoring tools

$8.8 B: Total handheld healthcare devices market

market size

How big?

Breathe Easy

1

Pharma

Industry

Drug Retail Stores

Insurers

Direct Sales

market

Revenue & Distribution

channels

How many devices can we sell?sales

• 4.3M children, 5-11 years

• 0,5% market penetration

• 259K devices per year

• at $69 each

Breathe Easy is raising…

$7.2M for the full way to sales

(36 months)

Convertible debt with 20%

discount and a valuation cap of

$36M

1st stage(36 months)

During 1st Stage…

36 months timeline to:

Case & Packaging design

100 Devices

Testing & FDA approval

Distribution Agreements

Sales Plan

1st stage(36 months)

Empowering children with asthma

proven concept

Breathe Easy: the Nike+ Sensor for kids with asthma

First Prize at MIT Health and Wellness

Innovation Competition 2012.